Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma
Active, not recruiting · NCT02998268 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma | esophageal adenocarcinoma | Active, not recruiting | Phase 2 | 2026-03-17 | NCT02998268 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| Weill Medical College of Cornell University | 276 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rhode Island Hospital | Providence | United States | 229 |
| University of Michigan | Ann Arbor | United States | 1 |
| USC Keck School of Medicine, Norris Cancer Center | Los Angeles | United States | 1 |
| Weill Cornell Medicine | New York | United States | 1 |